Research & Development



第八十章 火藥的正確用途   相比這些人,雲瑯更害怕那些帶病進入大漢國的人,尤其是一些致命的細菌。97资源共享   前者可以有足夠的能力來統領曹氏暗族,至于曹瑞,一定會被他那個胸大無腦的母親給培養成後一種人的。超碰97资源站   結果,霍去病並不相信,還沖著雲瑯伸出了中指!   西域所有的國家被雲瑯勒索了一次之後,又被劉陵洗劫了一次,那些土王的統治轟然倒塌。草莓在线观看   曹信鄙視的看了霍三一眼,跪坐在桌子邊上,雙手扶著大腿對長平道︰“阿祖,化學若是能用三兩句話說清楚,它就不是我西北理工的鎮山之寶。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo